<code id='8858F38746'></code><style id='8858F38746'></style>
    • <acronym id='8858F38746'></acronym>
      <center id='8858F38746'><center id='8858F38746'><tfoot id='8858F38746'></tfoot></center><abbr id='8858F38746'><dir id='8858F38746'><tfoot id='8858F38746'></tfoot><noframes id='8858F38746'>

    • <optgroup id='8858F38746'><strike id='8858F38746'><sup id='8858F38746'></sup></strike><code id='8858F38746'></code></optgroup>
        1. <b id='8858F38746'><label id='8858F38746'><select id='8858F38746'><dt id='8858F38746'><span id='8858F38746'></span></dt></select></label></b><u id='8858F38746'></u>
          <i id='8858F38746'><strike id='8858F38746'><tt id='8858F38746'><pre id='8858F38746'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:86593
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more
          A biotech analyst on neuroscience, placebo effect, not over
          A biotech analyst on neuroscience, placebo effect, not over

          PaulMatteis(right),in2017withthen-colleaguesSeamusFernandez(farleft)GeoffreyPorges.AlexHogan/STATNEW

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo